Modeling Cancer with Pluripotent Stem Cells

被引：28

作者：

Gingold, Julian ^{[1
]}

Zhou, Ruoji ^{[2
,3
]}

Lemischka, Ihor R. ^{[4
,5
,6
]}

Lee, Dung-Fang ^{[2
,3
,7
]}

机构：

[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA

[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA

[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA

[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA

[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 09期

关键词：

TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;

D O I：

10.1016/j.trecan.2016.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.

引用

页码：485 / 494

页数：10

共 50 条

[31] Human pluripotent stem cells for genetic disease modeling and drug screening
Gauthier, Morgane
Maury, Yves
Peschanski, Marc
Martinat, Cecile
REGENERATIVE MEDICINE, 2011, 6 (05) : 607 - 622
[32] Pluripotent Stem Cells for Livestock Health and Production
Punetha, Meeti
Bajwa, Kamlesh K.
Dua, Seema
Bansal, Sonu
Kuotsu, Vineichuno
Parashar, Atul
Selokar, Naresh L.
Kumar, Pradeep
Yadav, P. S.
Kumar, Dharmendra
CURRENT STEM CELL RESEARCH & THERAPY, 2022, 17 (03) : 252 - 266
[33] Current Methods and Challenges in the Comprehensive Characterization of Human Pluripotent Stem Cells
Asprer, Joanna S. T.
Lakshmipathy, Uma
STEM CELL REVIEWS AND REPORTS, 2015, 11 (02) : 357 - 372
[34] Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells
Lim, Wai Feng
Inoue-Yokoo, Tomoko
Tan, Keai Sinn
Lai, Mei I.
Sugiyama, Daisuke
STEM CELL RESEARCH & THERAPY, 2013, 4
[35] Retinal repair with induced pluripotent stem cells
Al-Shamekh, Shomoukh
Goldberg, Jeffrey L.
TRANSLATIONAL RESEARCH, 2014, 163 (04) : 377 - 386
[36] Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, Kamileh
Narsinh, Kazim H.
Wu, Joseph C.
CIRCULATION RESEARCH, 2011, 108 (09) : 1146 - 1156
[37] Regenerating the nephron with human pluripotent stem cells
Lam, Albert Q.
Bonventre, Joseph V.
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (02) : 187 - 192
[38] Engineering human cells and tissues through pluripotent stem cells
Jones, Jeffrey R.
Zhang, Su-Chun
CURRENT OPINION IN BIOTECHNOLOGY, 2016, 40 : 133 - 138
[39] Pluripotent stem cells as source of dendritic cells for immune therapy
Senju, Satoru
Hirata, Shinya
Motomura, Yutaka
Fukuma, Daiki
Matsunaga, Yusuke
Fukushima, Satoshi
Matsuyoshi, Hidetake
Nishimura, Yasuharu
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (03) : 392 - 400
[40] Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells
van Hugte, Eline
Kasri, Nael Nadif
FRONTIERS IN PSYCHIATRY: ARTIFCIAL INTELLIGENCE, PRECISION MEDICINE, AND OTHER PARADIGM SHIFTS, 2019, 1192 : 297 - 312

← 1 2 3 4 5 →